Studies on the physiologic disposition and activity of phenylpropanolamines in the mouse.
D000818:Animals; D001949:Bretylium Compounds / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D008680:Metaraminol / Q000037:antagonists & inhibitors / Q000378:metabolism; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D009411:Nerve Endings / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D010665:Phenylpropanolamine / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013154:Spleen / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014439:Tyramine / Q000494:pharmacology
D001949:Bretylium Compounds; D014316:Tritium; D010665:Phenylpropanolamine; D008680:Metaraminol; D012110:Reserpine; D003042:Cocaine; D003891:Desipramine; D009638:Norepinephrine; D014439:Tyramine; D006145:Guanethidine